Methotrexate Sodium
NDC Package 66758-040-08
Package Information
Methotrexate Sodium is methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. Marketed by Sandoz Inc., this product is identified by NDC 66758-040 and is authorized under FDA application ANDA090039.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 66758 - Sandoz Inc.
- 66758-040 - Methotrexate Sodium
- 66758-040-08 - 10 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE (66758-040-07)
- 66758-040 - Methotrexate Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (66758-040). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 66758-040-08 identifies a specific commercial package of 10 vial, single-dose in 1 carton / 10 ml in 1 vial, single-dose (66758-040-07) of Methotrexate Sodium, labeled by Sandoz Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sandoz Inc. on June 01, 2009. The current certification is valid through March 31, 2014.
What are the primary indications for this medication?
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function.
How is this Sandoz Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 66758004008. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.